News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
STARR KEVIN P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| STARR KEVIN P (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 11/03/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/12/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/16/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 1,900,000 shares
@ $8.38, valued at
$15.9M
|
|
| 11/12/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 11/05/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 09/24/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 09/17/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed of 1,750,000 shares
@ $0 |
|
| 08/11/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/17/2021 |
4
| STARR KEVIN P (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Bought 17,842 shares
@ $56.0466, valued at
$1000k
|
|
| 06/14/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed of 1,500,000 shares
@ $0 |
|
| 06/11/2021 |
4
| STARR KEVIN P (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $76.09, valued at
$760.9k
|
|
| 06/07/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Sold 378,117 shares
@ $30.2, valued at
$11.4M
Sold 164,996 shares
@ $30.23, valued at
$5M
|
|
| 05/27/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Sold 135,000 shares
@ $30.93, valued at
$4.2M
Sold 1,231,204 shares
@ $30.53, valued at
$37.6M
|
|
| 05/27/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 552,520 shares
@ $8, valued at
$4.4M
|
|
| 05/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/10/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Disposed of 1,085,784 shares
@ $0 |
|
| 03/15/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed of 1,250,000 shares
@ $0 |
|
| 03/03/2021 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 1,450,000 shares
@ $11.75, valued at
$17M
|
|
| 02/26/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Disposed of 1,500,000 shares
@ $0 |
|
| 02/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/12/2021 |
3
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 3 on Decibel Therapeutics, Inc. |
| 02/08/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Disposed of 914,216 shares
@ $0 |
|
| 01/14/2021 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 1,500,000 shares
@ $40, valued at
$60M
Sold 1,247,873 shares
@ $40.01, valued at
$49.9M
Sold 8,727 shares
@ $41.08, valued at
$358.5k
Sold 42,860 shares
@ $42.12, valued at
$1.8M
Sold 4,325 shares
@ $44, valued at
$190.3k
Sold 7,412 shares
@ $44.73, valued at
$331.5k
Sold 805,050 shares
@ $40.01, valued at
$32.2M
Sold 5,630 shares
@ $41.08, valued at
$231.3k
Sold 27,650 shares
@ $42.12, valued at
$1.2M
Sold 2,791 shares
@ $44, valued at
$122.8k
Sold 4,782 shares
@ $44.73, valued at
$213.9k
|
|
| 01/14/2021 |
4/A
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Relay Therapeutics, Inc. |
| 12/04/2020 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 11/23/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $7.005, valued at
$105.1k
|
|
| 11/19/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $7.2515, valued at
$108.8k
|
|
| 11/13/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 11/06/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 09/11/2020 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on Revolution Medicines, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
|
|
|